Prognostication in myelodysplastic syndromes: beyond the International Prognostic Scoring System (IPSS)
- PMID: 23507216
- PMCID: PMC3768129
- DOI: 10.1016/j.amjmed.2012.08.013
Prognostication in myelodysplastic syndromes: beyond the International Prognostic Scoring System (IPSS)
Comment on
-
Myelodysplastic syndromes: therapy and outlook.Am J Med. 2012 Jul;125(7 Suppl):S18-23. doi: 10.1016/j.amjmed.2012.04.018. Am J Med. 2012. PMID: 22735747 Review.
References
-
- Lyons RM. Myelodysplastic syndromes: therapy and outlook. Am J Med. 2012;125:S18–S23. - PubMed
-
- Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–2088. - PubMed
-
- Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25:3503–3510. - PubMed
-
- Komrokji RS, Corrales-Yepez M, Al Ali N, et al. Validation of the MD Anderson prognostic risk model for patients with myelodysplastic syndrome. Cancer. 2012;118:2659–2664. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical